Journal
KIDNEY INTERNATIONAL
Volume 74, Issue 3, Pages 300-309Publisher
ELSEVIER SCIENCE INC
DOI: 10.1038/ki.2008.179
Keywords
adenovirus; blood vessels; fibrosis; macrophages; renal disease
Categories
Funding
- Kidney Research UK [SF1/2008] Funding Source: researchfish
- Biotechnology and Biological Sciences Research Council Funding Source: Medline
Ask authors/readers for more resources
The loss of interstitial capillaries is a feature of several experimental models of renal disease and this contributes to secondary kidney injury. Angiopoietin-1 is a secreted growth factor which binds to Tie-2 present on endothelia to enhance cell survival thereby stabilizing capillary architecture in-vitro. Previous studies showed that angiopoietin-1 prevented renal capillary and interstitial lesions following experimental ureteric obstruction. We tested here the effect of angiopoietin-1 treatment on capillary loss and associated tubulointerstitial damage known to follow recovery from folic acid-induced tubular necrosis and acute renal injury. We found that delivery of angiopoietin-1 by adenoviral vectors stabilized peritubular capillaries in folic acid nephropathy but this was accompanied by profibrotic and inflammatory effects. These results suggest that the use of endothelial growth factor therapy for kidney disease may have varying outcomes that depend on the disease model tested.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available